81 related articles for article (PubMed ID: 30741319)
21. The histone deacetylase inhibitor trichostatin A induces neurite outgrowth in PC12 cells via the epigenetically regulated expression of the nur77 gene.
Tomioka T; Maruoka H; Kawa H; Yamazoe R; Fujiki D; Shimoke K; Ikeuchi T
Neurosci Res; 2014 Nov; 88():39-48. PubMed ID: 25128386
[TBL] [Abstract][Full Text] [Related]
22. Radio- and chemo-sensitization of human erythroleukemic K562 cells by the histone deacetylase inhibitor Trichostatin A.
Karagiannis TC; Smith AJ; El' Osta A
Hell J Nucl Med; 2004; 7(3):184-91. PubMed ID: 15841297
[TBL] [Abstract][Full Text] [Related]
23. Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines.
Asgar MA; Senawong G; Sripa B; Senawong T
Int J Oncol; 2016 Jan; 48(1):409-20. PubMed ID: 26575528
[TBL] [Abstract][Full Text] [Related]
24. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines.
Wang ZM; Hu J; Zhou D; Xu ZY; Panasci LC; Chen ZP
Ai Zheng; 2002 Oct; 21(10):1100-5. PubMed ID: 12508652
[TBL] [Abstract][Full Text] [Related]
25. The histone deacetylase inhibitor, Trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cells.
Anh TD; Ahn MY; Kim SA; Yoon JH; Ahn SG
Oncol Rep; 2012 Feb; 27(2):455-60. PubMed ID: 21993600
[TBL] [Abstract][Full Text] [Related]
26. Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer.
Li L; Fan B; Zhang LH; Xing XF; Cheng XJ; Wang XH; Guo T; Du H; Wen XZ; Ji JF
Tumour Biol; 2016 Aug; 37(8):10269-78. PubMed ID: 26831669
[TBL] [Abstract][Full Text] [Related]
27. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
28. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
29. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
[TBL] [Abstract][Full Text] [Related]
30. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
[TBL] [Abstract][Full Text] [Related]
31. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.
Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB
Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631
[TBL] [Abstract][Full Text] [Related]
32. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T
PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line.
Zhang QC; Jiang SJ; Zhang S; Ma XB
Asian Pac J Cancer Prev; 2012; 13(7):3471-6. PubMed ID: 22994780
[TBL] [Abstract][Full Text] [Related]
34. Cholera toxin, a typical protein kinase A activator, induces G1 phase growth arrest in human bladder transitional cell carcinoma cells via inhibiting the c-Raf/MEK/ERK signaling pathway.
Zheng X; Ou Y; Shu M; Wang Y; Zhou Y; Su X; Zhu W; Yin W; Li S; Qiu P; Yan G; Zhang J; Hu J; Xu D
Mol Med Rep; 2014 May; 9(5):1773-9. PubMed ID: 24626525
[TBL] [Abstract][Full Text] [Related]
35. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.
Shingu T; Holmes L; Henry V; Wang Q; Latha K; Gururaj AE; Gibson LA; Doucette T; Lang FF; Rao G; Yuan L; Sulman EP; Farrell NP; Priebe W; Hess KR; Wang YA; Hu J; Bögler O
J Transl Med; 2016 Feb; 14():46. PubMed ID: 26861698
[TBL] [Abstract][Full Text] [Related]
36. Effect of histone deacetylase inhibitor trichostatin A (TSA) on the microtubular system of Tetrahymena.
Kovács P; Pállinger E; Csaba G
Acta Biol Hung; 2007 Dec; 58(4):381-7. PubMed ID: 18277464
[TBL] [Abstract][Full Text] [Related]
37. Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function.
Wang P; Zhang P; Huang J; Li M; Chen X
Neurotoxicology; 2013 Jul; 37():51-62. PubMed ID: 23558232
[TBL] [Abstract][Full Text] [Related]
38. Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells.
Chen Z; Clark S; Birkeland M; Sung CM; Lago A; Liu R; Kirkpatrick R; Johanson K; Winkler JD; Hu E
Cancer Lett; 2002 Dec; 188(1-2):127-40. PubMed ID: 12406558
[TBL] [Abstract][Full Text] [Related]
39. PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer.
Chen L; Jin T; Zhu K; Piao Y; Quan T; Quan C; Lin Z
Oncotarget; 2017 Feb; 8(7):11937-11949. PubMed ID: 28060760
[TBL] [Abstract][Full Text] [Related]
40. Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells.
Pu YS; Chen J; Huang CY; Guan JY; Lu SH; Hour TC
J Urol; 2001 Jun; 165(6 Pt 1):2082-5. PubMed ID: 11371932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
